Recent Finacing
Recent Raise
Conatus Pharmaceuticals is a San Diego biopharmaceutical company developing liver disease and oncology therapeutics, advancing CTS-1027 — a Roche-licensed, clinical-stage drug in multiple Phase 2 trials for hepatitis C.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors